Join Now!

Begin our membership application process today!

Contact Us                                                                                                        

Kena Norris
Executive Director

312.227.7406
knorris@ccpapp.org

Priya Stemler
Director of Operations

312.227.7437
pstemler@ccpapp.org

Paresh Patel
National Sales Manager

312.227.7436
papatel@ccpapp.org

Jennifer Jackson
Sr. Administrative Assistant
312.227.7442
jdjackson@ccpapp.org
 
Sonia Perez Gandara
Member Relations Specialist

312.227.7508
sgandara@ccpapp.org

General Inquiries:
312.227.7444
info@ccpapp.org
 
 

Product Update for GARDASIL®9 (October 2018)

gardasilHomLogo
© 

Merck recently announced that the US Food and Drug Administration (FDA) has approved an expanded age indication for GARDASIL 9, Merck's 9-valent human papillomavirus (HPV) vaccine. GARDASIL 9 is now approved for use in appropriate patients ages 9 through 45 years to help protect against certain HPV-related cancers and diseases. The previous indication for GARDASIL 9 was for appropriate 9- to 26-year-olds. 

For more information please contact your Merck Vaccine Representative or call Merck Vaccine Customer Center at 1-877-829-6372.

Please also review Merck's GARDASIL 9 Product Update Announcement for details on indication, dosing schedule, packaging, CPT code, and NDC Number.

To view CCPAPP's contracted pricing for Merck's GARDASIL 9 and other vaccine products, please visit the pricing page of our website. Please email info@ccpapp.org if you are in need of your practice's account login information.

 

« Back

 
 

 

 

logo_Merck[1]

header_logo_sp[1]

 

 

LOGO_MMS

 

 

 

 
Copyright © 2021 CCPA Purchasing Partners. All rights reserved.
Web site design and development by Americaneagle.com